BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22180715)

  • 1. CpG island methylator phenotype in plasma is associated with hepatocellular carcinoma prognosis.
    Liu JB; Zhang YX; Zhou SH; Shi MX; Cai J; Liu Y; Chen KP; Qiang FL
    World J Gastroenterol; 2011 Nov; 17(42):4718-24. PubMed ID: 22180715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG island methylator phenotype and Helicobacter pylori infection associated with gastric cancer.
    Liu JB; Wu XM; Cai J; Zhang JY; Zhang JL; Zhou SH; Shi MX; Qiang FL
    World J Gastroenterol; 2012 Sep; 18(36):5129-34. PubMed ID: 23049225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
    Li B; Liu W; Wang L; Li M; Wang J; Huang L; Huang P; Yuan Y
    Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C; Li Z; Cheng Y; Jia F; Li R; Wu M; Li K; Wei L
    Clin Cancer Res; 2007 Feb; 13(3):944-52. PubMed ID: 17289889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation.
    Wu LM; Zhang F; Zhou L; Yang Z; Xie HY; Zheng SS
    BMC Cancer; 2010 Aug; 10():399. PubMed ID: 20678188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
    Liu WJ; Wang L; Wang JP; Li JQ; Zhang CQ; Zheng L; Yuan YF
    Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma.
    Cheng Y; Zhang C; Zhao J; Wang C; Xu Y; Han Z; Jiang G; Guo X; Li R; Bu X; Wu M; Wei L
    Exp Mol Pathol; 2010 Feb; 88(1):112-7. PubMed ID: 19879258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of CpG island methylator phenotype among hepatocellular carcinoma patients: A systematic review and meta-analysis.
    Wang Q; Wang G; Liu C; He X
    Int J Surg; 2018 Jun; 54(Pt A):92-99. PubMed ID: 29698791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma.
    Zhang C; Guo X; Jiang G; Zhang L; Yang Y; Shen F; Wu M; Wei L
    Int J Cancer; 2008 Sep; 123(5):998-1004. PubMed ID: 18546260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
    Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
    Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
    Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.
    Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH
    Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG island methylator phenotype of multigene in serum of sporadic breast carcinoma.
    Jing F; Yuping W; Yong C; Jie L; Jun L; Xuanbing T; Lihua H
    Tumour Biol; 2010 Aug; 31(4):321-31. PubMed ID: 20490964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation and environmental exposures in human hepatocellular carcinoma.
    Shen L; Ahuja N; Shen Y; Habib NA; Toyota M; Rashid A; Issa JP
    J Natl Cancer Inst; 2002 May; 94(10):755-61. PubMed ID: 12011226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Prosper F; Heiniger A; Torres A
    J Clin Oncol; 2005 Oct; 23(28):7043-9. PubMed ID: 16192589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer.
    Chen HY; Zhu BH; Zhang CH; Yang DJ; Peng JJ; Chen JH; Liu FK; He YL
    Cancer Sci; 2012 Jan; 103(1):73-9. PubMed ID: 22017425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma.
    Li G; Xu W; Zhang L; Liu T; Jin G; Song J; Wu J; Wang Y; Chen W; Zhang C; Chen X; Ding Z; Zhu P; Zhang B
    EBioMedicine; 2019 Sep; 47():128-141. PubMed ID: 31492561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG island methylator phenotype and its relationship with prognosis in adult acute leukemia patients.
    Fu HY; Wu DS; Zhou HR; Shen JZ
    Hematology; 2014 Sep; 19(6):329-37. PubMed ID: 24164743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
    Kusano M; Toyota M; Suzuki H; Akino K; Aoki F; Fujita M; Hosokawa M; Shinomura Y; Imai K; Tokino T
    Cancer; 2006 Apr; 106(7):1467-79. PubMed ID: 16518809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.